Paper
0
Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial
Authors
Journal
Published
Feb 22, 2016
Show more
Save
Tip0
TipSave
Abstract
AimsMigraine with aura and patent foramen ovale (PFO) are associated. The Percutaneous Closure of PFO in Migraine with Aura (PRIMA) trial is a multicentre, randomized trial to investigate the effect of percutaneous PFO closure in patients refractory to medical treatment.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.